News|Articles|August 28, 2023
How to Pave an Expressway to Phase I – Strategies That Accelerate Your Early-Phase Programs
Author(s)Wuxi
Speed is a critical factor in early-stage development. Solid state studies within an integrated CMC platform can support formulation development, accelerate timelines to Phase I clinical studies and increase the likelihood of successful clinical trial results.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
The FDA Moves to Modernize Drug Manufacturing Registration
2
PharmTech Weekly Roundup–July 10, 2026
3
The Implications of Isatuximab-irfc’s FDA Approval for Multiple Myeloma
4
What the Ocrelizumab Deal Does for the Multiple Sclerosis Biosimilar Pipeline
5